French Hypertrophic Cardiomyopathy Observatory
ConditionHypertrophic Cardiomyopathy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15+
SponsorFrench Cardiology Society
About this trial
Hypertrophic cardiomyopathy (Hypertrophic CardioMyopathy=HCM) remains a poorly understood disease with an assumption insufficiently codified. There is no data available in France on the profile of patients, diagnostic methods and assessment and therapeutic use.
The purpose of this study is to establish a monitoring of patients with HCM (sarcomere of origin or not) in France (diagnosis, treatment)
Eligibility criteria
Qualifiers
Age ≥ 15 years old
Patient with HCM defined by an ultrasound thickness of the left ventricle ≥ 13 mm if familial or ≥ 15 mm if sporadic
Disqualifiers
Expressed refusal to participate in the study
Significant aortic stenosis (<1 cm ²)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
600 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov